US Stocks Movers | Corcept Therapeutics Soars Nearly 21% Pre-market, Q2 Results Far Exceed Expectations
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data July 30｜Corcept Therapeutics surged nearly 21% in pre-market trading, quoted at $112.264. The company's second-quarter revenue was $256 million, higher than $194 million in the same period last year. This revenue exceeded analysts' expectations of $219 million by 16.8%. Earnings per share were $0.36, above the expected $0.02.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$73,508.38
-0.09%
Ethereum
ETH
$2,051.67
-0.35%
Tether USDt
USDT
$0.9991
+0.03%
BNB
BNB
$679.76
-0.45%
USDC
USDC
$0.9999
+0.01%
XRP
XRP
$1.05
-0.33%
Solana
SOL
$83.96
+0.43%
TRON
TRX
$0.3166
-0.78%
Hyperliquid
HYPE
$72.67
+0.10%
Zcash
ZEC
$982.55
-15.91%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now